Related references
Note: Only part of the references are listed.An impurity characterization based approach for the rapid development of integrated downstream purification processes
Steven M. Timmick et al.
BIOTECHNOLOGY AND BIOENGINEERING (2018)
Development of a general defined medium for Pichia pastoris
Catherine B. Matthews et al.
BIOTECHNOLOGY AND BIOENGINEERING (2018)
Making individualized drugs a reality (vol 35, pg 507, 2017)
Huub Schellekens et al.
NATURE BIOTECHNOLOGY (2017)
Digital-to-biological converter for on-demand production of biologics
Kent S. Boles et al.
NATURE BIOTECHNOLOGY (2017)
Patient-centered drug manufacture
NATURE BIOTECHNOLOGY (2017)
Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms
Catherine B. Matthews et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
N-terminal or Signal Peptide Sequence Engineering Prevents Truncation of Human Monoclonal Antibody Light Chains
S. J. Gibson et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics
Vibha Jawa et al.
AAPS JOURNAL (2016)
Comparative genomics and transcriptomics of Pichia pastoris
Kerry R. Love et al.
BMC GENOMICS (2016)
Portable, On-Demand Biomolecular Manufacturing
Keith Pardee et al.
CELL (2016)
On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system
Andrea Adamo et al.
SCIENCE (2016)
Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care
Pablo Perez-Pinera et al.
NATURE COMMUNICATIONS (2016)
Comparability of Biosimilar Filgrastim with Originator Filgrastim: Protein Characterization, Pharmacodynamics, and Pharmacokinetics
Fritz Soergel et al.
BIODRUGS (2015)
White Paper on Continuous Bioprocessing May 20-21, 2014 Continuous Manufacturing Symposium
Konstantin B. Konstantinov et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production
Mudassar Ahmad et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Humanization of yeast to produce complex terminally sialylated glycoproteins
Stephen R. Hamilton et al.
SCIENCE (2006)
Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b
S Hermeling et al.
PHARMACEUTICAL RESEARCH (2005)
Aggregation of granulocyte colony stimulating factor under physiological conditions: Characterization and thermodynamic inhibition
S Krishnan et al.
BIOCHEMISTRY (2002)
Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF) -: results of a prospective randomised monocentre study
H Bönig et al.
BONE MARROW TRANSPLANTATION (2001)
Share Paper
